ArticleTranslational cancer research2025

APOA2 mediates immune therapy tolerance in hepatocellular carcinoma by inhibiting the antigen-presenting function of dendritic cells through the PPAR signaling pathway.

Junwu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.